These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6213322)
21. Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol. Venturoli S; Paradisi R; Saviotti E; Porcu E; Fabbri R; Orsini LF; Bovicelli L; Flamigni C Arch Gynecol; 1985; 237(1):1-10. PubMed ID: 2932064 [TBL] [Abstract][Full Text] [Related]
22. Spironolactone as a single agent for long-term therapy of hirsute patients. Spritzer PM; Lisboa KO; Mattiello S; Lhullier F Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338 [TBL] [Abstract][Full Text] [Related]
23. Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network. Cea Soriano L; Asiimwe A; García Rodriguez LA Contraception; 2017 Mar; 95(3):299-305. PubMed ID: 27769766 [TBL] [Abstract][Full Text] [Related]
24. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review. Bitzer J; Römer T; Lopes da Silva Filho A Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):172-182. PubMed ID: 28447864 [TBL] [Abstract][Full Text] [Related]
25. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms. Acién P; Mauri M; Gutierrez M Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733 [TBL] [Abstract][Full Text] [Related]
26. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism. Seed M; Godsland IF; Wynn V; Jacobs HS Clin Endocrinol (Oxf); 1984 Dec; 21(6):689-99. PubMed ID: 6239714 [TBL] [Abstract][Full Text] [Related]
27. Cyproterone acetate treatment of females with hyperandrogenism. Julesz J; Faredin I; Tóth I; László FA Endokrinologie; 1981 Dec; 78(2-3):168-74. PubMed ID: 6460612 [TBL] [Abstract][Full Text] [Related]
28. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters. Parr JH; Seed M; Godsland I; Wynn V J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418 [TBL] [Abstract][Full Text] [Related]
29. Effect of cyproterone acetate-ethinyl oestradiol treatment on adrenal function in hirsute women. Chapman MG; Jeffcoate SL; Dewhurst CJ Clin Endocrinol (Oxf); 1982 Dec; 17(6):577-82. PubMed ID: 6299625 [TBL] [Abstract][Full Text] [Related]
30. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Mastorakos G; Koliopoulos C; Creatsas G Fertil Steril; 2002 May; 77(5):919-27. PubMed ID: 12009344 [TBL] [Abstract][Full Text] [Related]
32. [Effect of cyproterone acetate on the secretion ACTH, cortisol and testosterone, and on the urinary elimination of 17-OHCS and 17-CS in hirsute females]. Djurić DS; Manojlović D Endocrinologie; 1981; 19(1):59-63. PubMed ID: 6270779 [No Abstract] [Full Text] [Related]
33. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome. Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220 [TBL] [Abstract][Full Text] [Related]
34. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate. Salva P; Morer F; Ordoñez J; Rodriguez J Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068 [TBL] [Abstract][Full Text] [Related]
35. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive. Negri P; Agnello G; Borghesani F; Tomain L; Minisci N; D'Errico G; Cavallini AR Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501 [TBL] [Abstract][Full Text] [Related]
36. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate. Armstrong VL; Wiggam MI; Ennis CN; Sheridan B; Traub AI; Atkinson AB; Bell PM QJM; 2001 Jan; 94(1):31-7. PubMed ID: 11161134 [TBL] [Abstract][Full Text] [Related]
37. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients. Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518 [TBL] [Abstract][Full Text] [Related]
38. Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects. Marcondes JA; Wajchenberg BL; Abujamra AC; Luthold WW; Samojlik E; Kirschner MA Fertil Steril; 1990 Jan; 53(1):40-4. PubMed ID: 2136835 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol]. Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318 [TBL] [Abstract][Full Text] [Related]
40. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism. Anderson JA Br J Dermatol; 1978 Nov; 99(5):545-52. PubMed ID: 708628 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]